Solel plans $25m. upgrade

In 2006-2007 Solel received orders for over 100,000 receivers from power plant operators and developers in the US and Spain.

By MATTHEW KRIEGER
May 9, 2007 06:52

 
X

Dear Reader,
As you can imagine, more people are reading The Jerusalem Post than ever before. Nevertheless, traditional business models are no longer sustainable and high-quality publications, like ours, are being forced to look for new ways to keep going. Unlike many other news organizations, we have not put up a paywall. We want to keep our journalism open and accessible and be able to keep providing you with news and analyses from the frontlines of Israel, the Middle East and the Jewish World.

As one of our loyal readers, we ask you to be our partner.

For $5 a month you will receive access to the following:

  • A user experience almost completely free of ads
  • Access to our Premium Section
  • Content from the award-winning Jerusalem Report and our monthly magazine to learn Hebrew - Ivrit
  • A brand new ePaper featuring the daily newspaper as it appears in print in Israel

Help us grow and continue telling Israel’s story to the world.

Thank you,

Ronit Hasin-Hochman, CEO, Jerusalem Post Group
Yaakov Katz, Editor-in-Chief

UPGRADE YOUR JPOST EXPERIENCE FOR 5$ PER MONTH Show me later

Solel Solar Systems Ltd. said Tuesday it will build a new facility near its Beit Shemesh headquarters, thereby tripling the company's capacity for manufacturing its solar thermal receiver systems. The new facility, in which the company will invest $25 million, is being constructed partly in response to significant increases in orders for Solel's renewable solar energy systems and recent agreements by Solel to build solar thermal power plants in Spain. In 2006-2007 Solel received orders for over 100,000 receivers from power plant operators and developers in the US and Spain.

Join Jerusalem Post Premium Plus now for just $5 and upgrade your experience with an ads-free website and exclusive content. Click here>>

Related Content

The Teva Pharmaceutical Industries
April 30, 2015
Teva doubles down on Mylan, despite rejection

By GLOBES, NIV ELIS